Adherence to both pharmacologic and nonpharmacologic regimens will result in the largest impact on hyperlipidemia, and patients should be individually assessed to determine the most appropriate ones for them.
Jennifer Borowski, PharmD
Advertisement
Articles by Jennifer Borowski, PharmD
Advertisement
Latest Updated Articles
- Many Options Now Available to Treat Hyperlipidemia
Published: December 1st 2007 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
2
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
3
Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer
4
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
5
